PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24465398-7	2014	RESULTS: By univariate analysis, both melphalan and topotecan appear to be associated with changes in ERG amplitude at both 3 and 12 months; but for the most part, these changes are minimal and likely clinically insignificant.	Melphalan	38-47	ETS transcription factor ERG	Homo sapiens	102-105	
24465398-8	2014	By multivariate analysis, maximum and cumulative melphalan have a modest, temporary effect on the ERG amplitude change, which is apparent at 3 months but no longer evident at 12 months after completing treatment.	Melphalan	49-58	ETS transcription factor ERG	Homo sapiens	98-101